Analysts Offer Insights on Healthcare Companies: BridgeBio Pharma (BBIO), Aurinia Pharmaceuticals (AUPH) and 908 Devices (MASS)
TipRanksMay 2 14:22
Buy Rating Affirmed for 908 Devices Amidst PAT Growth and Solid Financial Outlook
TipRanksMar 7 12:16
Stifel Nicolaus Remains a Buy on 908 Devices (MASS)
TipRanksMar 6 20:36
Stephens & Co. Reiterates Overweight on 908 Devices, Maintains $14 Price Target
BenzingaSep 25, 2023 21:50
908 Devices Analyst Ratings
BenzingaSep 25, 2023 21:49
908 Devices (MASS) Receives a Buy From SVB Securities
TipRanksMar 9, 2023 12:06
908 Devices Analyst Ratings
Benzinga Analyst RatingsFeb 7, 2023 18:05
Stephens & Co. Initiates Coverage On 908 Devices With Overweight Rating, Announces Price Target of $14
Benzinga Real-time NewsFeb 7, 2023 18:05
Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), 908 Devices (MASS) and Privia Health Group (PRVA)
TipRanksJan 18, 2023 20:55
SVB Securities Sticks to Its Buy Rating for 908 Devices (MASS)
TipRanksJan 7, 2023 00:30
SVB Securities Adjusts 908 Devices' Price Target to $20 From $30, Keeps Outperform Rating
MT NewswiresJan 6, 2023 23:59
908 Devices Analyst Ratings
Benzinga Analyst RatingsJan 6, 2023 22:12
SVB Securities Keeps Their Buy Rating on 908 Devices (MASS)
TipRanksNov 15, 2022 20:40
908 Devices Analyst Ratings
Benzinga Analyst RatingsNov 15, 2022 17:47
No Data
No Data